The Valley Desk

ArticleLancet regional health. AmericasPublished

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium

12 of 45 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Listed An author affiliation on the Europe PMC record names Virtua Health. Affiliation source

Institution
Virtua Health

Publication record

Type
Article
Venue
Lancet regional health. Americas
Published
Subject terms
Cancer; Vaccination; Mrna Vaccine; Breakthrough Infection; Covid-19; Sars-cov-2
PubMed ID
36818595
PubMed Central ID
PMC9925160
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal